NATERA, INC. Accounts Receivable, Allowance for Credit Loss, Writeoff
NATERA, INC. (NTRA) reported Accounts Receivable, Allowance for Credit Loss, Writeoff of $369.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Notes › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs · last filed 2023-03-01
- NATERA, INC. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2021-12-31 was $1.14M.
- NATERA, INC. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2021-09-30 was $0.00.
- NATERA, INC. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2021-06-30 was $385.00K, a 575.44% increase year-over-year.
- NATERA, INC. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2021-03-31 was $110.00K, a 72.50% decline year-over-year.
- NATERA, INC. accounts receivable, allowance for credit loss, writeoff for fiscal 2022 was $369.00K, a 77.43% decline from fiscal 2021.
- NATERA, INC. accounts receivable, allowance for credit loss, writeoff for fiscal 2021 was $1.64M, a 257.77% increase from fiscal 2020.
- NATERA, INC. accounts receivable, allowance for credit loss, writeoff for fiscal 2020 was $457.00K, a 4470.00% increase from fiscal 2019.
- NATERA, INC. accounts receivable, allowance for credit loss, writeoff for fiscal 2019 was $10.00K, a 94.15% decline from fiscal 2018.
| Period end | Accounts Receivable, Allowance for Credit Loss, Writeoff 3 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 6 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 9 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 12 month |
|---|---|---|---|---|
| 2022-12-31 | $369.00K 10-K · filed 2023-03-01 | |||
| 2021-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.14M derived: sum of 2 quarters · filed 2023-03-01 | $1.52M derived: sum of 3 quarters · filed 2023-03-01 | $1.64M 10-K · filed 2023-03-01 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $385.00K derived: sum of 2 quarters · filed 2021-11-05 | $495.00K 10-Q · filed 2021-11-05 | $495.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $385.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $495.00K 10-Q · filed 2021-08-06 | $495.00K derived: sum of 3 quarters · filed 2023-03-01 | $495.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $110.00K 10-Q · filed 2021-05-07 | $110.00K derived: sum of 2 quarters · filed 2023-03-01 | $110.00K derived: sum of 3 quarters · filed 2023-03-01 | $167.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $57.00K derived: sum of 3 quarters · filed 2023-03-01 | $457.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $57.00K derived: sum of 2 quarters · filed 2020-11-06 | $457.00K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $457.00K 10-Q · filed 2020-08-07 | ||
| 2020-03-31 | $400.00K 10-Q · filed 2020-05-08 | |||
| 2019-12-31 | $10.00K 10-K · filed 2022-02-25 | |||
| 2018-12-31 | $171.00K 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $33.00K 10-K · filed 2020-03-02 | |||
| 2016-12-31 | $65.00K 10-K · filed 2019-03-15 | |||
| 2015-12-31 | $85.00K 10-K · filed 2018-03-15 | |||
| 2014-12-31 | $330.00K 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |